An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine
- 31 August 2000
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 80 (4-5), 185-189
- https://doi.org/10.1054/tuld.2000.0244
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Human T Cell Responses to the ESAT‐6 Antigen fromMycobacterium tuberculosisThe Journal of Infectious Diseases, 1999
- Differential T cell responses toMycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donorsEuropean Journal of Immunology, 1998
- A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)Microbiology, 1998
- Production of avirulent Mycobacterium bovis strains by illegitimate recombination with deoxyribonucleic acid fragments containing an interrupted ahpC geneTubercle and Lung Disease, 1997
- The Potential of the ESAT-6 Antigen Secreted by Virulent Mycobacteria for Specific Diagnosis of TuberculosisThe Journal of Infectious Diseases, 1997
- Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteriaFEMS Microbiology Letters, 1996
- Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovisJournal of Bacteriology, 1996
- Auxotrophic vaccines for tuberculosisNature Medicine, 1996
- Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium aviumJournal of Bacteriology, 1991